Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
| Trades 252 | Longs Won 212/252 84% | Profit Factor 51.4 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $779,459.77 |
| Average Win $218,941.77 | Best Trade (Jul 15) $6.58M | Sharpe Ratio -14.09 |
| Average Loss -$22,573.96 | Worst Trade (Jul 13) -$230,088.91 | Z-Score 17.6 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m | Expectancy $180,605.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,696 | 7,826 | 6,957 | 6,087 | 5,217 | 4,348 | 3,478 | 2,609 | 1,739 | 870 |